HIV

Scientific Focus

Gilead Research Scholars Gilead Research Scholars
  • Available Programs
  • Login / Register
Gilead Research Scholars
  • Program Overview
    • Scientific Focus
    • Scientific Review Committee
    • Eligibility
    • Criteria For Selection
  • Application Information
    • Proposal & Budget Guidelines
    • Program Timeline
    • Inquiries/Contact Information
    • Downloads
  • Applications
  • Award Recipients
  • Contact
  • FAQ

Program Overview

Gilead Sciences Research Scholars Program in HIV

 The program is designed to support basic, translational and clinical research in the field of HIV. Areas of research may include, but are not limited to:

  • HIV treatment and management 
  • HIV and its complications in special populations (aging, women, people of color, etc)
  • HIV prevention
  • Basic, translational and clinical research related to HIV

Awards granted under the program may not be duplicative of funding from institutional or hospital, other governmental, non-governmental, or industry sources. Applicants seeking an award for research projects that are currently receiving or may receive partial funding from other sources are required to submit appropriate evidence, including budget information related to the other sources, to demonstrate that there is no direct overlap or duplication in funding.

Proposals are reviewed by an independent Scientific Review Committee (no Gilead Commercial involvement in review and selection, i.e., Marketing, Sales, and Commercial Strategy) based upon the criteria outlined on this website.

Proposals utilizing Gilead product(s) are not eligible for funding through the Research Scholars Program.  Proposals involving Gilead product(s) should not be submitted for review under the Investigator-Sponsored Research Grant Program through the ISR online portal.

  • Scientific Focus
  • Scientific Review Committee
  • Eligibility
  • Criteria For Selection

GILEAD and the GILEAD logo are registered trademarks of Gilead Sciences, Inc., or one of its related companies.

© 2020 Gilead Sciences, Inc. All rights reserved. 

Privacy Policy 

Terms of Use 

Funding Considerations